Hepatorenal Findings in Obligate Heterozygotes for Autosomal Recessive Polycystic Kidney Disease

Por Gunay-Aygun, Meral, Turkbey, Ismail Baris, Bryant, Joy, Daryanani, Kailash T., Gerstein, Maya Tuchman, Piwnica-Worms, Katie, Choyke, Peter, Heller, Theo, Gahl, William A.
Publicado em 2011

Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1α (HIF-1α) in Advanced Solid Tumors

Por Kummar, Shivaani, Raffeld, Mark, Juwara, Lamin, Horneffer, Yvonne, Strassberger, Agnes, Allen, Deborah, Steinberg, Seth M., Rapisarda, Annamaria, Spencer, Shawn D., Figg, William D., Chen, Xiaohong, Turkbey, Ismail Baris, Choyke, Peter, Murgo, Anthony J., Doroshow, James H., Melillo, Giovanni
Publicado em 2011

CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olapari...

Por Lee, Jung-Min, Trepel, Jane B., Choyke, Peter, Cao, Liang, Sissung, Tristan, Houston, Nicole, Yu, Minshu, Figg, William D., Turkbey, Ismail Baris, Steinberg, Seth M., Lee, Min-Jung, Ivy, S. Percy, Liu, Joyce F., Matulonis, Ursula A., Kohn, Elise C.
Publicado no Front Oncol (2015)